Correlation Between Cingulate Warrants and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Checkpoint Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Checkpoint Therapeutics.
Diversification Opportunities for Cingulate Warrants and Checkpoint Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and Checkpoint is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Checkpoint Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 18.38 times more return on investment than Checkpoint Therapeutics. However, Cingulate Warrants is 18.38 times more volatile than Checkpoint Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 26.00 in Cingulate Warrants on September 12, 2024 and sell it today you would lose (22.37) from holding Cingulate Warrants or give up 86.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 75.35% |
| Values | Daily Returns |
Cingulate Warrants vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Checkpoint Therapeutics |
Cingulate Warrants and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Checkpoint Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Cingulate Warrants vs. Equillium | Cingulate Warrants vs. DiaMedica Therapeutics | Cingulate Warrants vs. Valneva SE ADR | Cingulate Warrants vs. Vivani Medical |
| Checkpoint Therapeutics vs. Equillium | Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Valneva SE ADR | Checkpoint Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |